Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...

Gamifant marks the first-ever FDA-approved treatment for both adult and pediatric patients with hemophagocytic ...

The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.

Treatment with salanersen slowed neurodegeneration and improved motor function in children with SMA in a Phase 1 trial, ...

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

Diabetes is one of the most common health conditions in the world, which can cause serious complications and manifest as skin ...

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune ...

Experts share their tips on preventing measles during travel, including when to get vaccinated and how long to isolate if infected, in light of recent measles outbreaks and new CDC measles travel ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

Chronic pain, sexual dysfunction and incontinence can all stem from problems with your pelvic floor — and many men don’t even ...

Serious concerns continue to mount over the impact of HIV in Fiji, as eight children were among the 126 people who died from ...